These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 24273937

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of architect I 2000 for determination of cyclosporine with axsym.
    Serdarevic N, Zunic L.
    Acta Inform Med; 2012 Dec; 20(4):214-7. PubMed ID: 23378685
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL, De S, Jimenez E, McMillin GA, De BK.
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [Abstract] [Full Text] [Related]

  • 4. Detection of squamous cell carcinoma antigen with two systems in the follow-up of patients with cervical cancer.
    Sandri MT, Salvatici M, Mauro C, Radice D, Lentati P, Massaro MA, Boveri S, Zorzino L, Landoni F.
    Int J Biol Markers; 2013 Sep 27; 28(3):313-7. PubMed ID: 23722302
    [Abstract] [Full Text] [Related]

  • 5. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
    De BK, Jimenez E, De S, Sawyer JC, McMillin GA.
    Clin Chim Acta; 2009 Dec 27; 410(1-2):25-30. PubMed ID: 19751714
    [Abstract] [Full Text] [Related]

  • 6. Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® system.
    Hermida-Cadahia EF, Tutor JC.
    Scand J Clin Lab Invest; 2012 Apr 27; 72(2):180-3. PubMed ID: 22248047
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma.
    Chen H, Tian L, Chen J, Sun P, Han R, Wu X, Dai S.
    Cancer Control; 2020 Apr 27; 27(1):1073274820983025. PubMed ID: 33356502
    [Abstract] [Full Text] [Related]

  • 8. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA, Cooke RR, Weinstein P, Nacey JN.
    Ann Clin Biochem; 2004 May 27; 41(Pt 3):207-12. PubMed ID: 15117434
    [Abstract] [Full Text] [Related]

  • 9. Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer.
    Holdenrieder S, Molina R, Qiu L, Zhi X, Rutz S, Engel C, Kasper-Sauer P, Dayyani F, Korse CM.
    Tumour Biol; 2018 Apr 27; 40(4):1010428318772202. PubMed ID: 29701125
    [Abstract] [Full Text] [Related]

  • 10. [Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV)].
    Petitjean Lecherbonnier J, Gouarin S, Dina J, Vabret A, Freymuth F.
    Pathol Biol (Paris); 2007 Dec 27; 55(10):512-20. PubMed ID: 17959324
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.
    Strauss HG, Laban C, Lautenschläger C, Buchmann J, Schneider I, Koelbl H.
    Eur J Cancer; 2002 Oct 27; 38(15):1987-91. PubMed ID: 12376202
    [Abstract] [Full Text] [Related]

  • 13. Squamous cell carcinoma antigen in patients with cancer of the larynx.
    Lachowicz MA, Hassmann-Poznańska E, Kozłowski MD, Rzewnicki I.
    Clin Otolaryngol Allied Sci; 1999 Aug 27; 24(4):270-3. PubMed ID: 10472458
    [Abstract] [Full Text] [Related]

  • 14. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
    Bouzas L, Tutor JC.
    Clin Biochem; 2007 Jan 27; 40(1-2):132-6. PubMed ID: 17011541
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer.
    Lin H, ChangChien CC, Huang EY, Tseng CW, Eng HL, Huang CC.
    Acta Obstet Gynecol Scand; 2000 Feb 27; 79(2):140-4. PubMed ID: 10696963
    [Abstract] [Full Text] [Related]

  • 18. [Clinical significance of SCC antigen assay as a tumor marker].
    Kato H.
    Nihon Rinsho; 1990 Feb 27; 48 Suppl():1057-9. PubMed ID: 2192106
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.